Octane Announces Neuro Tech Forum 2026 to Advance Neurotechnology Innovation

Octane announced that the Octane Neuro Tech Forum 2026 will take place March 26-27, 2026, at VEA Newport Beach, A Marriott Resort & Spa in Newport Beach, California. The event brings together industry leaders, clinicians, investors and entrepreneurs to advance innovation in neurotechnology. The forum is part of Octane’s Innovation Event Series and will feature keynote speaker Dr. Adnan Siddiqui, CEO and CMO of the Jacobs Institute, along with more than 30 expert speakers addressing emerging neurotech technologies, digital health innovation, brain-computer interfaces and the evolving investment landscape.

The forum will include innovation panels, investor-focused sessions, company presentations and networking opportunities designed to foster partnerships and accelerate development of next-generation neurotechnology solutions. This gathering matters because neurotechnology represents one of the most promising frontiers in medical technology, with potential applications ranging from treating neurological disorders to enhancing human capabilities through brain-computer interfaces. By creating a dedicated forum for this emerging field, Octane is facilitating crucial conversations that could shape the future of healthcare and technology.

The importance of this announcement lies in the timing and focus of the event. With neurotechnology advancing rapidly, bringing together diverse stakeholders from clinical, investment, and entrepreneurial backgrounds creates opportunities for cross-pollination of ideas and resources. The inclusion of investor-focused sessions indicates recognition that funding and commercialization pathways are essential for translating neurotech innovations from research to real-world applications. The emphasis on brain-computer interfaces specifically highlights one of the most transformative areas within neurotechnology, where recent breakthroughs have captured both scientific and public imagination.

Octane fosters a future-focused ecosystem of tech and medtech companies across Southern California by connecting people, resources, and capital. The organization’s mission is to drive innovation and growth by facilitating the exchange of ideas, knowledge, and resources that fuel the growth and development of Southern California’s tech and medtech industries. This neurotech forum represents a targeted application of that mission within a specific high-potential sector. The implications extend beyond the event itself, potentially catalyzing new collaborations, investments, and research directions that could accelerate neurotechnology development in the coming years.

The Neuro Tech Forum 2026 announcement signals growing institutional support for neurotechnology as a distinct field requiring specialized forums for knowledge exchange and partnership development. By creating this dedicated space for neurotech innovation, Octane is addressing a need for more focused conversation around the unique challenges and opportunities in this rapidly evolving sector. The event’s location in Southern California, a hub for both technology and medical innovation, positions it to leverage regional strengths while attracting national and international participation. For more information about Octane’s broader initiatives, visit https://www.octaneoc.org.